Antipsychotic Polypharmacy
نویسندگان
چکیده
منابع مشابه
Antipsychotic polypharmacy: squandering precious resources?
BRAINSTORMS is a monthly section of The Journal of Clinical Psychiatry aimed at providing updates of novel concepts emerging from the neurosciences that have relevance to the practicing psychiatrist. From the Neuroscience Education Institute in Carlsbad, Calif., and the Department of Psychiatry at the University of California San Diego. Reprint requests to: Stephen M. Stahl, M.D., Ph.D., Editor...
متن کاملRegional variation in antipsychotic polypharmacy for schizophrenia.
ED FROM Baandrup L, Allerup P, Nordentoft M, et al. Exploring regional variation in antipsychotic coprescribing practice: a Danish questionnaire survey. J Clin Psychiatry 2010;71:1457–64. Correspondence to: Lone Baandrup, Center for Neuropsychiatric Schizophrenia Research, Copenhagen University Hospital, Psychiatric Center Glostrup, Nordre Ringvej 29–67, DK-2600 Glostrup, Denmark; lone.baandrup...
متن کاملAntipsychotic Polypharmacy – time to review practice
The largest UK audit of APP was conducted by the Prescribing Observatory for Mental Health (POMHUK). A baseline audit of 3492 patients on 218 wards found that 43% were prescribed APP, and over onethird prescribed a high-dose of antipsychotic medication. A recent audit of APP at Graylands hospital, using a similar methodology to POMH-UK, found that 89.8% of patients were prescribed more than one...
متن کاملCost of antipsychotic polypharmacy in the treatment of schizophrenia
BACKGROUND This study compared the costs of antipsychotic polypharmacy for patients who initiated on 1 of the 3 most commonly prescribed atypical antipsychotics - olanzapine, quetiapine, or risperidone. METHODS Data were drawn from a large, prospective, naturalistic, multi-site, nonrandomized study of treatment for schizophrenia in the United States conducted between July 1997 and September 2...
متن کاملEmerging guidelines for the use of antipsychotic polypharmacy.
Although combining medications for the treatment of schizophrenia is the rule rather than the exception, the literature and treatment guidelines consistently direct clinicians away from this practice, emphasizing that antipsychotic polypharmacy/combination treatments are associated with higher medication costs, more side effects, and no clearly documented improvement in efficacy and in fact, wo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Psychiatric Clinics of North America
سال: 2012
ISSN: 0193-953X
DOI: 10.1016/j.psc.2012.06.007